James and Esther King Biomedical Research Program
Limited submission
The James and Esther King Biomedical Research Program funds innovative research in Florida targeting cancer, cardiovascular, pulmonary, stroke, and tobacco-related diseases.
Funder: Florida James and Esther King Biomedical Research Program
Due Dates: August 19, 2026 (Questions) | August 26, 2026 (LOI) | October 13, 2026 (Full application)
Funding Amounts: Up to $1,500,000 total for most categories (36–48 months); smaller mechanisms available (e.g., Equipment/Bridge: $100,000; New Investigator/High-Risk: $300,000–$750,000). Indirect costs capped at 15%.
Summary: Supports innovative biomedical research in Florida focused on prevention, diagnosis, treatment, and cure of cancer, cardiovascular disease, stroke, pulmonary disease, and tobacco-related illnesses.
Key Information: LOI is required and must be submitted by the deadline to be eligible.
Description
The Florida James and Esther King Biomedical Research Program provides competitive grant funding to Florida-based universities and established research institutes for biomedical research projects that address cancer, cardiovascular disease, stroke, pulmonary disease, and diseases related to tobacco use. The program aims to improve prevention, diagnosis, treatment, and cure of these diseases, enhance biomedical knowledge, strengthen Florida’s research infrastructure, and stimulate economic growth in health-related sectors.
Multiple grant categories are available, including clinical trials, discovery science, emerging therapeutics, new investigator awards, equipment, and research infrastructure. Projects must demonstrate a clear relationship to tobacco-related diseases and/or cancer and show potential to impact public health in Florida.
